4.8 Article

ZIF-8 Metal-Organic Framework Electrochemical Biosensor for the Detection of Protein-Protein Interaction

Journal

CHEMISTRY OF MATERIALS
Volume 33, Issue 4, Pages 1293-1306

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.chemmater.0c04201

Keywords

-

Funding

  1. FAPESP
  2. CAPES
  3. CNPq

Ask authors/readers for more resources

A new label-free electrochemical biosensor based on Zeolitic Imidazole Framework (ZIF-8) was developed for monitoring protein-protein interactions (PPIs). The ZIF-8 crystals exhibited a rhombic dodecahedral structure with mainly exposed facets and a mean particle size of 205 (+/- 22) nm. The biosensor demonstrated higher sensitivity and reproducibility compared to the conventional solid-phase binding assay.
In this study, a novel label-free electrochemical biosensor based on the zeolitic imidazole framework (ZIF-8) was developed for monitoring protein-protein interactions (PPIs). ZIF-8 was deposited on interdigitated electrodes and employed as a transducing material and simultaneously carried the thioredoxin-1 (Trx- 1) protein, followed by the deposition of increased concentrations of the cytoplasmic domain of a disintegrin and metalloproteinase 17 (ADAM17cyto) known as the Trx-1 binding partner. Structural and morphological characterizations were used to validate and verify the formation of ZIF-8. The ZIF-8 crystals showed a rhombic dodecahedral structure with mainly exposed (011) facets, a mean particle size of 205 (+/- 22) nm, and a ZIF-8 film thickness around 61 (+/- 6) nm. The interaction between Trx-1 and ADAM17cyto proteins was analyzed through electrochemical impedance spectroscopy (EIS). The results indicate a linear and inverse relationship between the impedance responses at 0.1 Hz for ADAM17cyto concentrations from 50 nM to 8 mu M, with a coefficient of variation from 1.0% to 11.4%. The proposed biosensor also displayed a significant selectivity and stability verified by using ADAM17cyto mutant and BSA as controls. As a proof-of-concept, we compared the results with a widely used type of PPI assay based on antibody recognition, the solid-phase binding assay, using the same proteins. The solid-phase binding assay was able to detect a significant binding only in ADAM17cyto concentrations above 0.5 mu M, with a coefficient of variation varying from 5.4% to 27.5%. The results demonstrate that the developed biosensor was 10x more sensitive and reproducible than the conventional solid-phase binding assay. Furthermore, the developed electrochemical biosensor based on ZIF-8 provides a faster, label-free, and low-cost detection analysis, representing a novel strategy in detecting PPIs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available